More Stories

Informist, Tuesday, Aug. 4, 2026

 

Please click here to read all liners published on this story

--Metropolis Health Apr-Jun consol net profit INR 566.67 mln 
--Analysts saw Metropolis Health Apr-Jun consol net profit at INR 546.50 mln 
--Metropolis Health Apr-Jun consol revenue INR 4.50 bln 
--Analysts saw Metropolis Health Apr-Jun consol revenue at INR 4.45 bln 
--Metropolis Health Q1 consol PAT INR 566.67 mln vs INR 450.60 mln yr ago 
--Metropolis Health Q1 consol revenue INR 4.50 bln vs INR 3.86 bln yr ago 

 

By Diksha Singh

 

MUMBAI – Metropolis Healthcare Ltd. reported higher-than-estimated net profit and revenue for the June quarter. The company reported a consolidated net profit of INR 566.67 million for Apr-Jun, up 26% on year from INR 451 million. Analysts' had estimated the company's average net profit at INR 546.50 million.

 

The company's consolidated revenue from operations grew 17% to INR 4.50 billion from INR 3.86 billion in the year-ago period. This was marginally above the Street estimate of INR 4.45 billion. The company's total income, including other income, rose 16% to INR 4.55 million. The total expenses of the company reported for the June quarter rose nearly 14% on year to INR 3.78 billion. The employee benefits expense rose 16% to INR 1.07 billion, and other expenses rose 16% to INR 1.39 billion.  

 

Metropolis Healthcare reported earnings before interest, tax, depreciation, and amortisation of INR 1.13 billion for the June quarter, up 27% from INR 891 million in the year-ago quarter. The EBITDA margin expanded 210 basis points to 25.2% from 23.1%. The earnings before interest and tax is up 30.6% on year to INR 860 million.

 

In the June quarter, patient volume increased 10% and test volume rose 11% on year, driven by sustained demand, deeper market penetration, and a market shift toward trusted diagnostic chains, Metropolis said in a press release.

 

The revenue from the business-to-consumer segment rose 18% on year through strong brand pull, targeted micro-marketing, and expanding digital engagement, the company said. The company's revenue from the business-to-business segment rose 15% on year, on the back of improvement in business quality and expansion of its clinician and institutional network. The company's revenue from TruHealth, a range of preventive full-body health checkups, rose 22% on year to INR 810 million, constituting 18% of the total revenue of the company. The revenue from the speciality business grew 17% on year to INR 1.78 billion, contributing 40% to the company's revenue. 

 

Consequently, the revenue per patient increased by 6% on year, and revenue per test improved by 5% on year due to richer test mix and higher contribution from specialised diagnostics. The tier three cities were the fastest growing markets for Metropolis Healthcare, with revenue growth of 25% on year, outperforming the 11% and 14% growth seen in tier one and tier two cities, respectively.

 

"We remain focused on enhancing productivity, driving operational excellence and delivering sustainable, profitable growth," Surendran Chemmenkotil, managing director of the company said in the press release.

 

Tuesday, the company's shares closed at INR 584.50 apiece on the National Stock Exchange, down 2% from Monday. Metropolis Healthcare announced its June quarter earnings after market hours.  End

 

Edited by Deepshikha Bhardwaj

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000 

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2026. All rights reserved.